Enzymotec wins Israeli phytosterol patent

Related tags Denmark European union New zealand

Israeli-based lipid specialist, Enzymotec, has been granted a home turf patent for the composition and production of its phytosterol ingredient, Cardiobeat.

The patent follows previous approvals granted in China and New Zealand as well as new dietary ingredient status in the US and novel food approval in the European Union.

Further process and efficacy patents are pending in other international jurisdictions.

CardiaBeat, derived from an omega-3 glyceride matrix, has been shown to reduce the likelihood of cardiovascular disease in clinical trials.

Related news

Show more

Related products

show more

Golden Omega® Sustainability Strategy

Golden Omega® Sustainability Strategy

Content provided by LEHVOSS Nutrition | 11-Sep-2023 | Data Sheet

Commitment to sustainability at Golden Omega® is ever growing as they continue to put objectives in place to secure a better environment for the future....

Uncover the Potential of Kombucha in APAC

Uncover the Potential of Kombucha in APAC

Content provided by Lumina Intelligence | 02-Aug-2023 | White Paper

The paper explores consumer engagement in the APAC region concerning Kombucha products and probiotic juices, along with the factors that drive this engagement.

Omega-3:Nutrition and Application Insight

Omega-3:Nutrition and Application Insight

Content provided by Cabio Biotech (Wuhan) Co., Ltd | 31-Jul-2023 | White Paper

Omega-3 long-chain polyunsaturated fatty acids (PUFAs) have numerous positive health benefits and are among the most extensively studied micronutrients....

Related suppliers

Follow us


View more